These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17185807)

  • 1. Microgravity and drug effects on bone.
    Shapiro JR
    J Musculoskelet Neuronal Interact; 2006; 6(4):322-3. PubMed ID: 17185807
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonates and osteonecrosis: potential treatment or serious complication?
    Goytia RN; Salama A; Khanuja HS
    Orthop Clin North Am; 2009 Apr; 40(2):223-34. PubMed ID: 19358907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A query from medical practice: the biological half-life of biphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2008 Dec; 133(51-52):2700-1. PubMed ID: 19067274
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone loss prevention in cancer: new developments and perspectives.
    Lipton A
    Semin Oncol; 2010 Jun; 37 Suppl 1():S1-2. PubMed ID: 20682366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis and treatment of immobilization osteoporosis].
    Inoue D
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bisphosphonate and mechanical stress on bone].
    Endo I; Matsumoto T
    Clin Calcium; 2008 Sep; 18(9):1321-6. PubMed ID: 18758038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current controversies in bisphosphonate therapy.
    Paul GR
    Orthopedics; 2010 Jul; 33(7):468. PubMed ID: 20608598
    [No Abstract]   [Full Text] [Related]  

  • 8. Sympathetic neural influence on bone metabolism in microgravity (Review).
    Mano T; Nishimura N; Iwase S
    Acta Physiol Hung; 2010 Dec; 97(4):354-61. PubMed ID: 21138811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criticality of kyphoplasty and vertebroplasty.
    Verdoia C; Macchi V; Bernieri J; Corradini C
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):47-8. PubMed ID: 21970921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged bisphosphonate release after treatment in children.
    Papapoulos SE; Cremers SC
    N Engl J Med; 2007 Mar; 356(10):1075-6. PubMed ID: 17347467
    [No Abstract]   [Full Text] [Related]  

  • 12. Skeletal responses to space flight and the bed rest analog: a review.
    LeBlanc AD; Spector ER; Evans HJ; Sibonga JD
    J Musculoskelet Neuronal Interact; 2007; 7(1):33-47. PubMed ID: 17396004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of diphosphonates on the metabolism of calcium, its regulation and the state of the bone tissue in the modelling of the physiological effects of weightlessness].
    Orlov OI; Shashkov VS; Grigor'ev AI
    Eksp Klin Farmakol; 1992; 55(5):61-5. PubMed ID: 1305460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High bone-binding capacity of ibandronate in hemodialysis patients.
    Bergner R; Henrich D; Hoffmann M; Lenz T; Bals G; Ullmann M; Uppenkamp M
    Int J Clin Pharmacol Res; 2005; 25(3):123-31. PubMed ID: 16366420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
    [No Abstract]   [Full Text] [Related]  

  • 16. [Morphological study of early changes in rat bones during exposure to simulated weightlessness].
    Kaplanskiĭ AS; Sakharova ZF; El'ina-Kakueva EI; Dyrnova GN
    Kosm Biol Aviakosm Med; 1987; 21(6):36-9. PubMed ID: 3437739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates and bone turnover in premenopausal women receiving adjuvant chemotherapy.
    Paterson A; Baker T
    J Clin Oncol; 2009 Mar; 27(7):1005-6. PubMed ID: 19171701
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
    Brufsky AM
    Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].
    Miki T; Minamide T
    Clin Calcium; 2007 Jan; 17(1):18-22. PubMed ID: 17211089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoporosis in patients under treatment for cancer and the possibilities for prevention and treatment].
    Eekhoff EM; Pinedo HM; Lips P
    Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1388-93. PubMed ID: 17668601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.